López ML, Bacallao MR, González NL, Rodríguez López-Calleja CA, De La Concepción GOM, Matos TM

Language: Spanish
References: 20
Page: 122-130
PDF size: 497.51 Kb.

ABSTRACT

Aldosterone-producing adenomas (Conn's syndrome) are responsible for most cases of primary aldosteronism. Observing small benign tumors, usually well defined, single and less than two cm, located at the adrenal cortex. We report a case of a 43 years old man with hypertension unsensitive to medical treatment of four years of evolution, during the last year started with muscle weakness and cramps. In the ionogram was found hypokalemia and a left adrenal tumor on CT scan. In addition we have found a marked elevation of plasma aldosterone, plasma renin activity ratio, hence primary aldosteronism is diagnosed secondary to Conn's tumor. Laparoscopic adrenalectomy was performed and the histological study of the anatomical piece showed the presence of a mixed cortical adenoma. On the electron microscopy study there were cytoplasmic eosinophilic inclusions corresponding to spironolactone bodies. It is the first time that spironolactone bodies are described in Cuban medical literature.

REFERENCES

1. Conn JW. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955;45:317.

2. Kaplan N. Primary aldosteronism. In: Clinical Hypertension. 9th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006:410-433.

3. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40.

4. Lim PO, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens. 2000;14:311-315.

5. Rayner BL, Opie LH, Davidson JS. The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J. 2000;90:394-400.

6. McKenna, TJ, Sequeira, SJ, Heffernan, A, et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73:952.

7. -Hinchliffe E, Carter S, Owen LJ, Keevil BG. Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 28; 913-914C:19-23.

8. Ducher M, Mounier-Véhier C, Baguet JP, Tartière JM, Sosner P, Régnier-Le Coz S, Pérez L, Fourcade J, Jabourek O, Lejeune S, Stolz A, Fauvel JP. Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study. Arch Cardiovasc Dis. 2012; 105(12):623-30.

9. Al-Salameh A, Cohen R, Chanson P, Plouin PF. Update on endocrine hypertension. Ann Endocrinol. 2012;73 Suppl 1:S26-35.

10. Lin YC, Lee HY, Juang GD, Yeh CH, Cheng YH, Chuo KY, Chen HE, Tsai TF, Hwang TI. Technical modification of retroperitoneal laparoscopic adrenalectomy for primary hyperaldosteronism and clinical outcomes. Asian J Surg. 2013; 36(1):20-5.

11. Lim, PO, Young, WF, MacDonald, TM. A review of the medical treatment of primary aldosteronism. J Hypertens 2001; 19:353.

12. Mulatero, P, Stowasser, M, Loh, KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89:1045.

13. Layden BT, Hahr AJ, Elaraj DM. Primary hyperaldosteronism: challenges in subtype classification. BMC Res Notes. 2012; 5:602.

14. Funder, JW, Carey, RM, Fardella, C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93:3266.

15. Young, DB. Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 1988; 255:F811.

16. Potthoff SA, Beuschlein F, Vonend O. Primay hyperaldosteronism - diagnostic and treatment. Dtsch Med Wochenschr. 2012;137(48):2480-4.

17. Hirohara, D, Nomura, K, Okamoto, T, et al. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab 2001; 86:4292.

18. Vaughan ED Jr. Diseases of the adrenal gland. Med Clin North Am 2004 Mar;88(2):443-66.

19. Kovacs K, Hovarth E and Singer W. Fine structure and morphogenesis of spironolactone bodies in the zone glomerulosa of the human adrenal cortex. J. Clin Pathol 1973; 26: 949-57.

20. Su-Ming H, Raine L, and Martin H. Spironolactone bodies. An immunoperoxidase study with biochemical correlation. Am J Clin Pathol 1981;75:92-5.